Enhance your nephrology practice with CME and tools focused on kidney medicine.
The Podocyte Problem: Understanding FSGS
Kirk Campbell, MD
Alessia Fornoni, MD, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP
Claudia Seikrit, MD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
Emilio Sanchez, MD, PhD
CKD-aP or Something Else? Decoding the Diagnosis
Improving Sleep and Mental Health in Patients with CKD-aP
Leonie Kraft, MD
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
CKD-aP Treatment Tool Kit
Is CKD-aP Hiding in Your Dialysis Center?
Quantifying CKD-aP: Tools for Better Care
Elevating CKD-aP Care: New Frontier
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Ellie Kelepouris, MD, FACP, FAHA
Javed Butler, MD, MPH, MBA
Potassium Binders: Safety Comes First!
Potassium Binders in Practice: Clinical Trial Evidence
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Nihar R. Desai, MD, MPH
CKD-aP: Beyond the Surface
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Treatment Revolution in IgA Nephropathy
Shikha Wadhwani, MD
Dana Rizk, MD
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.